Eye4Health’s Strategic Approach to Loss of Exclusivity Analysis
Eye4Health offers pharmaceutical companies an integrated LOE analysis approach tailored to commercial and legal needs. Our analysis helps clients navigate LOE challenges through three practical components.
1. Comprehensive Market Impact Analysis
Our LOE analysis begins with a detailed market impact assessment focused on:
Competitive landscape: Identifying likely market entrants and evaluating generic competitor strategy.
Pricing and revenue projections: Estimating likely revenue and market-share decline using scenario modelling.
Lifecycle extension opportunities: Identifying options such as pricing adjustments, product enhancements, and portfolio optimisation.
This allows teams to plan early, mitigate financial impact, and maintain market presence through transition.
2. Analytical Support for Legal Teams
Eye4Health does not provide direct legal services, but we do provide high-level analytical support that helps legal teams defend intellectual property and prepare for LOE-related disputes. Support includes:
Patent litigation support: Detailed economic and market analysis to strengthen legal positioning.
Economic impact assessments: Data-led estimates of potential lost revenue and disruption risk.
Scenario modelling: Alternative market scenarios based on different legal outcomes.
These outputs help legal teams prepare stronger, evidence-backed arguments.
3. Proactive Transition Management
Navigating the shift from exclusivity to a competitive market requires forward planning. Eye4Health supports transition strategy through:
Brand defence strategies: Maintaining market positioning and loyalty in the face of generic competition.
Alternative revenue streams: Identifying opportunities in partnerships, licensing, and adjacent portfolio options.
Optimised pricing models: Balancing profitability with competitiveness to retain share where possible.
Our objective is to help teams protect value and execute a structured post-exclusivity plan.
Case Study: Analytical Support During LOE
A global pharmaceutical company approaching LOE for a top-performing drug engaged Eye4Health to support both market planning and legal preparation.
Market impact analysis: We mapped likely generic entrants, pricing dynamics, and projected revenue pressure to establish financial exposure.
Legal analytical support: We developed economic models and market-impact evidence that were used by legal teams during hearings to support patent defence strategy.
This integrated support contributed to a successful defence, delaying generic entry and extending the product’s revenue-generating period.
The Eye4Health Advantage
Eye4Health combines market analytics and legal-support modelling in a single LOE workflow. Clients benefit from:
In-depth market impact insight for earlier, clearer decision-making.
Specialised legal analytical support for patent and regulatory disputes.
Strategic transition planning to maximise value through and beyond LOE.
Conclusion
Loss of exclusivity is a high-stakes lifecycle phase that demands structured planning and robust evidence. Eye4Health helps pharmaceutical teams manage market impact, support legal defences with solid analytics, and protect portfolio value during transition.
About Eye4Health Ltd
Eye4Health Ltd is a consultancy specialising in loss-of-exclusivity analysis for the pharmaceutical industry. We support clients with market impact assessment, legal analytical support, and transition strategy to help them navigate LOE successfully.